Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients.

Seok Y, Lee WK, Park JY, Kim DS.

Mol Cells. 2019 Feb 28;42(2):161-165. doi: 10.14348/molcells.2018.0322. Epub 2019 Jan 24.

2.

TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery.

Lee YH, Do SK, Lee SY, Kang HG, Choi JE, Hong MJ, Lee JH, Lee EB, Jeong JY, Shin KM, Lee WK, Seok Y, Cho S, Yoo SS, Lee J, Cha SI, Kim CH, Jheon S, Park JY.

Thorac Cancer. 2019 Feb;10(2):335-340. doi: 10.1111/1759-7714.12951. Epub 2018 Dec 26.

3.

Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.

Do SK, Jeong JY, Lee SY, Choi JE, Hong MJ, Kang HG, Lee WK, Seok Y, Lee EB, Shin KM, Yoo SS, Lee J, Cha SI, Kim CH, Neugent ML, Goodwin J, Kim JW, Park JY.

Ann Surg Oncol. 2018 Oct;25(11):3396-3403. doi: 10.1245/s10434-018-6677-1. Epub 2018 Jul 30.

PMID:
30062472
4.

Intronic variant of EGFR is associated with GBAS expression and survival outcome of early-stage non-small cell lung cancer.

Hong MJ, Lee SY, Choi JE, Kang HG, Do SK, Lee JH, Yoo SS, Lee EB, Seok Y, Cho S, Jheon S, Lee J, Cha SI, Kim CH, Park JY.

Thorac Cancer. 2018 Aug;9(8):916-923. doi: 10.1111/1759-7714.12757. Epub 2018 May 28.

5.

Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancer.

Shin KM, Hong MJ, Lee SY, Jin CC, Baek SA, Lee JH, Choi JE, Kang HG, Lee WK, Seok Y, Lee EB, Jeong JY, Yoo SS, Lee J, Cha SI, Kim CH, Kim YC, Oh IJ, Na KJ, Cho S, Jheon S, Park JY.

Gene. 2018 Mar 10;646:56-63. doi: 10.1016/j.gene.2017.12.055. Epub 2017 Dec 29.

PMID:
29289609
6.

Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer.

Kang HG, Yoo SS, Choi JE, Hong MJ, Do SK, Jin CC, Kim S, Lee WK, Choi SH, Lee SY, Kim HJ, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Cho S, Jheon S, Park JY.

Oncotarget. 2017 Jun 27;8(37):61777-61785. doi: 10.18632/oncotarget.18693. eCollection 2017 Sep 22.

7.

Association between polymorphisms in microRNA target sites and survival in early-stage non-small cell lung cancer.

Yoo SS, Hong MJ, Lee JH, Choi JE, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Cho S, Jheon S, Park JY.

Thorac Cancer. 2017 Nov;8(6):682-686. doi: 10.1111/1759-7714.12478. Epub 2017 Sep 18.

8.

Salvage radiotherapy for regional lymph node oligo-recurrence after radical surgery of non-small cell lung cancer.

Seol KH, Lee JE, Cho JY, Lee DH, Seok Y, Kang MK.

Thorac Cancer. 2017 Nov;8(6):620-629. doi: 10.1111/1759-7714.12497. Epub 2017 Sep 14.

9.

Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.

Seok Y, Kang HG, Lee SY, Jeong JY, Choi JE, Jung DK, Jin CC, Hong MJ, Do SK, Lee WK, Park JY, Shin KM, Yoo SS, Lee J, Cho S, Cha SI, Kim CH, Jheon S, Lee EB, Park JY.

Ann Surg Oncol. 2017 Oct;24(11):3386-3395. doi: 10.1245/s10434-017-6002-4. Epub 2017 Aug 1.

PMID:
28766235
10.

Effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer.

Yoo SS, Kang HG, Choi JE, Do SK, Lee WK, Choi SH, Lee SY, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Kim MS, Lee JM, Cho HJ, Oh IJ, Kim YC, Cho S, Jheon S, Jung CY, Kim MH, Lee MK, Park JY.

Cancer Genet. 2017 Apr;212-213:8-12. doi: 10.1016/j.cancergen.2017.03.003. Epub 2017 Mar 20.

PMID:
28449811
11.

Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter study.

Lee WK, Lee SY, Choi JE, Seok Y, Lee EB, Lee HC, Kang HG, Yoo SS, Lee MH, Cho S, Jheon S, Kim YC, Oh IJ, Na KJ, Jung CY, Park CK, Kim MH, Lee MK, Park JY.

Thorac Cancer. 2017 May;8(3):251-259. doi: 10.1111/1759-7714.12434. Epub 2017 Mar 31.

12.

Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.

Seok Y, Jeong JY, Lee E.

Thorac Cancer. 2017 May;8(3):197-202. doi: 10.1111/1759-7714.12424. Epub 2017 Feb 21.

13.

Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.

Lee SY, Jung DK, Choi JE, Jin CC, Hong MJ, Do SK, Kang HG, Lee WK, Seok Y, Lee EB, Jeong JY, Shin KM, Yoo SS, Lee J, Cha SI, Kim CH, Park JY.

Gene. 2017 Jan 30;599:28-35. doi: 10.1016/j.gene.2016.11.007. Epub 2016 Nov 10.

PMID:
27838455
14.

Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer.

Lee SY, Jin CC, Choi JE, Hong MJ, Jung DK, Do SK, Baek SA, Kang HJ, Kang HG, Choi SH, Lee WK, Seok Y, Lee EB, Jeong JY, Shin KM, Cho S, Yoo SS, Lee J, Cha SI, Kim CH, Lee YM, Lee IK, Jheon S, Park JY.

Sci Rep. 2016 Oct 21;6:35603. doi: 10.1038/srep35603.

15.

The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.

Lee S, Kang HG, Choi JE, Lee JH, Kang HJ, Baek SA, Lee E, Seok Y, Lee WK, Lee SY, Yoo SS, Lee J, Cha SI, Kim CH, Cho S, Park JY.

J Korean Med Sci. 2016 Nov;31(11):1735-1741. doi: 10.3346/jkms.2016.31.11.1735.

16.

Polymorphisms in cancer-related pathway genes and lung cancer.

Lee SY, Kang HG, Choi JE, Jung DK, Lee WK, Lee HC, Lee SY, Yoo SS, Lee J, Seok Y, Lee EB, Cha SI, Cho S, Kim CH, Lee MH, Park JY.

Eur Respir J. 2016 Oct;48(4):1184-1191. doi: 10.1183/13993003.02040-2015. Epub 2016 Sep 1.

17.

Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.

Seok Y, Lee E.

Thorac Cardiovasc Surg. 2018 Mar;66(2):150-155. doi: 10.1055/s-0036-1586757. Epub 2016 Aug 12.

PMID:
27517168
18.

Inadvertently transected left superior pulmonary vein during thoracoscopic left lower lobectomy.

Seok Y, Lee E.

J Cardiothorac Surg. 2016 May 26;11(1):84. doi: 10.1186/s13019-016-0469-0.

19.

PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy.

Lee SY, Jung DK, Choi JE, Jin CC, Hong MJ, Do SK, Kang HG, Lee WK, Seok Y, Lee EB, Jeong JY, Shin KM, Yoo SS, Lee J, Cha SI, Kim CH, Park JY.

Sci Rep. 2016 May 16;6:25952. doi: 10.1038/srep25952.

20.

Perioperative outcomes of upper lobectomy according to preservation or division of the inferior pulmonary ligament.

Seok Y, Yi E, Cho S, Jheon S, Kim K.

J Thorac Dis. 2015 Nov;7(11):2033-40. doi: 10.3978/j.issn.2072-1439.2015.11.41.

Supplemental Content

Loading ...
Support Center